Compound ID | 1915
Synonym(s): Moxalactam | Moxam | LY127935 | LY-127935 | LY 127935 | 6059-S
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor. Binds to bacterial penicillin-binding proteins (PBP); PBP inhibitor |
| Target Pathogen: | Primarily Enterobacteriaceae: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter spp., Citrobacter spp., Serratia marcescens, Salmonella spp., Shigella spp., and weaker/moderate activity against Streptococcus pneumoniae, Streptococcus pyogenes, other streptococci and some Staphylococcus aureus |
| Propensity to select resistant mutants: | Low–Moderate initially; increasing due to ESBLs and β-lactamases |
| Description: | Semisynthetic Cephalosporine (oxacephem), derived from Cephalosporin C |
| Institute where first reported: | Shionogi and Co., Ltd. |
| Year first mentioned: | 1977 |
| Highest development stage: | Withdrawn |
| Development status: | Approved |
| Reason dropped: | Prolonged bleeding time |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/47499 |
| Guide to Pharmacology: | latamoxef |
| Citations: |
|
| Patent: | DE2713370A1 |